A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)

Clinical trial NCT07011043 · RECRUITING

Trial details

NCT number: NCT07011043
Sponsor: Climb Bio, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2025-07-10
Primary completion: 2027-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.